Drug intelligence / Profile preview

AGN1 LOEP SV Kit

Development stage
Unknown
Lead developer
AgNovos Healthcare
Administration
Intravertebral
01

Overview

The AGN1 LOEP SV Kit is an investigational medical device developed by AgNovos Healthcare for the treatment of stable but painful vertebral compression fractures (VCFs), typically associated with osteoporosis. The kit utilizes a proprietary, calcium-based, resorbable, tri-phasic implant material known as AGN1. During the procedure, the material is injected into the fractured vertebral body following saline lavage. Unlike traditional polymethylmethacrylate (PMMA) bone cement, which remains as a permanent foreign body, AGN1 is designed to be osteoconductive, allowing it to be gradually resorbed and replaced by the patient's natural bone. This biological approach aims to restore vertebral strength while potentially reducing the risk of subsequent fractures in adjacent vertebrae.

Brand names
AGN1 LOEP SV KitAGN-1 LOEP SV KitAGN 1 LOEP SV Kit
Other names
AGN1 Local Osteo-enhancement Procedure Small Volume KitAGN-1 Local Osteo-enhancement Procedure Small Volume KitAGN 1 Local Osteo-enhancement Procedure Small Volume KitAGN1 implant materialAGN-1 implant materialAGN 1 implant material

Beyond the preview

Go deeper on AGN1 LOEP SV Kit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AGN1 LOEP SV Kit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call